150mg PD 537 (Celontin 150 mg)
Generic Name: methsuximide
Pill imprint 150mg PD 537 has been identified as Celontin 150 mg.
Celontin is used in the treatment of seizures and belongs to the drug class succinimide anticonvulsants. FDA has not classified the drug for risk during pregnancy. Celontin 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
Celontin
- Generic Name:
- methsuximide
- Imprint:
- 150mg PD 537
- Strength:
- 150 mg
- Color:
- White & Yellow
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Succinimide anticonvulsants
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- 00071-0537
More about Celontin (methsuximide)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
